• Journal Article

Patients' benefit-risk preferences for chronic Idiopathic thrombocytopenic purpura (ITP) therapies

Citation

Hauber, A., Johnson, F., Grotzinger, K., & Ozdemir, S. (2010). Patients' benefit-risk preferences for chronic Idiopathic thrombocytopenic purpura (ITP) therapies. Annals of Pharmacotherapy, 44(3), 479 - 88.

Abstract